A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis

NCT07748637 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis (MS)

Interventions

BIOLOGICAL: GT802 Injection

Sponsor

Daishi Tian

Collaborators

[object Object]